entertainment -WSS

entertainment

author：fashion 2025-09-03 14:39:37 - browse：9

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

WSS

Roche drug slashes death risk in early

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

For longer

Study on Amgen’s bispecific immunotherapy produces positive data

Questions loom on AstraZeneca cancer drug as safety concerns ebb

J&J lung cancer data amount to new salvo against AstraZeneca

leisure time

entertainment

focus

Peter Hotez and the public health issue of online harassment

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Sports medicine is finally prioritizing gender equality

Liver decline slowed by off

Sports medicine is finally prioritizing gender equality

CZI to create biohub to build anti

DIEP, the 'gold standard' of breast reconstruction, is under threat

Making the case for fair compensation in clinical trials

Hepatitis C has a cure — but many Americans still lack access to it

Liver decline slowed by off

entertainment

Digital health: a case of mistaken identity

UnitedHealth argues against case alleging wrongful AI care denials

FDA poised to publish guidelines for clinical trial diversity

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Making the case for fair compensation in clinical trials

Fentanyl is making it harder to start addiction treatment

leisure time

hotspot

leisure time

Wikipedia